Biologics growth transforms API market

The global market for APIs is being transformed as biologic ingredients make up an increasing share of the overall $78 billion market, with biologic ingredients set to grow 12 percent to 15 percent per year to reach $12 billion by 2011. Report

Suggested Articles

The real estate impresario that built a chain of upscale drug recovery facilities is now building a gene and cell therapy CDMO near Philadelphia.

The seven-year Astellas venture served as a model for Amgen's recent $2.7 billion tie-up with BeiGene in China—and now it's amping up there, too.

Pfizer's Upjohn has reached a deal to exclusively supply generic Viagra to telehealth provider Roman as the company prepares to merge with Mylan.